Supramolecular Organization As a Factor of Ribonuclease Cytotoxicity

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Therapeutics

Background:

• Targeting tumor cell RNA is a strategy for cancer treatment.
• Secreted ribonucleases (RNases) have largely unexplored therapeutic potential.
• The antitumor and antiviral effects of RNases are traditionally attributed to their catalytic activity.

Purpose of the Study:

• To review the cytotoxic effects of secreted RNases beyond their catalytic activity.
• To investigate the role of RNase structure in selective cancer cell cytotoxicity.
• To propose a new therapeutic strategy for RNase-based antitumor drugs.

Main Methods:

• Literature review of studies on secreted RNases and cancer cells.
• Analysis of data on non-catalytic cytotoxic effects of RNases.
• Evaluation of the role of enzyme structure in cell component interaction.

Main Results:

• Recent studies challenge the exclusive role of enzymatic activity in RNase-induced cancer cell cytotoxicity.
• The structural organization of RNases is crucial for their selective apoptosis-inducing action.
• Non-catalytic interactions between RNases and cancer cells significantly contribute to selective cytotoxicity.

Conclusions:

• The therapeutic potential of RNases in cancer treatment is significant.
• Non-catalytic interactions, driven by RNase structure, are key to selective cytotoxicity.
• This understanding can guide the development of novel, structure-based RNase antitumor drugs.